Abstract
Nitric oxide (NO) is one of the first gases discovered by Joseph Priestley in 1772. For more than 200 years, it was considered mainly as an environmental pollutant and product of bacterial metabolism. In 1980, Furchgott and Zawadzki reported a substance released from endothelial cells which is responsible for the relaxation of arterial smooth muscle by acetylcholine’. They named this substance endothelium-derived relaxing factor (EDRF). EDRF was proven to be NO in the late 1980s2-4. Since NO is known to be generated in many different mammalian cells, a deluge of articles has implicated this ubiquitous molecule in a wide variety of regulatory mechanisms ranging from vascular tone to neurotransmissions. NO is also involved in nonspecific immunity and participates in the complex mechanism of tissue injury, acting as a major mediator of inflammation-related processes6,7
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Furchgott, R.F. and J.V. Zawadzki (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.Nature288(5789), 373–376.
Feelisch, M., M. te Poel, R. Zamora, A. Deussen, and S. Moncada (1994). Understanding the controversy over the identity of EDRF.Nature368(6466), 62–65.
Palmer, R.M., A.G. Ferrige, and S. Moncada (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.Nature327(6122), 524–526.
Ignarro, L.J., G.M. Buga, K.S. Wood, R.E. Byrns, and G. Chaudhuri (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.Proc. Natl. Acad. Sci. USA84(24), 9265–9269.
Moncada, S. and A. Higgs (1993). The L-arginine-nitric oxide pathway.N. Engl. J. Med.329(27), 2002–12.
Nussler, A.K. and T.R. Billiar (1993). Inflammation, immunoregulation, and inducible nitric oxide synthase.J. Leukoc. Biol.54(2), 171–178.
Zamora, R., Y. Vodovotz, and T.R. Billiar (2000). Inducible nitric oxide synthase and inflammatory diseases.Mol. Med.6(5), 347–373.
Hertz, M.I., D.O. Taylor, E.P. Trulock, M.M. Boucek, P.J. Mohacsi, L.B. Edwardset al.(2002). The registry of the international society for heart and lung transplantation: Nineteenth official report-2002.J. Heart Lung Transplant.21(9), 950–970.
Lamas, S., P.A. Marsden, G.K. Li, P. Tempst, and T. Michel (1992). Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform.Proc. Natl. Acad. Sci. USA89(14), 6348–6352.
Nishida, K., D.G. Harrison, J.P. Navas, A.A. Fisher, S.P. Dockery, M. Uematsuet al.(1992). Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase.J. Clin. Invest.90(5), 2092–6.
Sessa, W.C., J.K. Harrison, C.M. Barber, D. Zeng, M.E. Durieux, D.D. D’Angeloet al.(1992). Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase.J. Biol. Chem.267(22), 15274–15276.
Bredt, D.S., P.M. Hwang, C.E. Glatt, C. Lowenstein, R.R. Reed, and S.H. Snyder (1991). Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.Nature351(6329), 714–718.
Xie, Q.W., H.J. Cho, J. Calaycay, R.A. Mumford, K.M. Swiderek, T.D. Leeet al.(1992). Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.Science256(5054), 225–228.
Lyons, C.R., G.J. Orloff, and J.M. Cunningham (1992). Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line.J. Biol. Chem.267(9), 6370–6374.
Geller, D.A., C.J. Lowenstein, R.A. Shapiro, A.K. Nussler, M. Di Silvio, S.C. Wanget al.(1993). Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.Proc. Natl. Acad. Sci. USA90(8),3491–3495.
Chartrain, N.A., D.A. Geller, RP. Koty, N.F. Sitrin, A.K. Nussler, E.P. Hoffmanet al.(1994). Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene.J. Biol. Chem.269(9), 6765–6772.
Leber, A., B. Hemmens, B. Klosch, W. Goessler, G. Raber, B. Mayeret al.(1999). Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeastPichia pastoris. J. Biol. Chem.274(53), 37658–37664.
Ghafourifar, P. and C. Richter (1997). Nitric oxide synthase activity in mitochondria.FEBS Lett.418(3), 291–296.
Ghafourifar, P., U. Schenk, S.D. Klein, and C. Richter (1999). Mitochondrial nitric-oxide synthase stimulation cUSAes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation.J. Biol. Chem.274(44), 31185–31188.
Bredt, D.S. and S.H. Snyder (1994). Nitric oxide: A physiologic messenger molecule.Annu. Rev. Biochem.63, 175–195.
Forstermann, U., E.I. Closs, J.S. Pollock, M. Nakane, P. Schwarz, I. Gathet al.(1994). Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.Hypertension.23(6 Pt 2), 1121–1131.
Morris, S.M. Jr. and T.R. Billiar (1994). New insights into the regulation of inducible nitric oxide synthesis. Am.J. Physiol.266(6 Pt 1), E829–E839.
Nathan, C. and Q.W. Xie (1994). Nitric oxide synthases: Roles, tolls, and controls.Cell.78(6), 915–918.
Hinescu, M.E. (2001). Cardiac apoptosis: From organ failure to allograft rejection.J. Cell Mol. Med.5(2), 143–152.
Hernandez, L.A., M.B. Grisham, and D.N. Granger (1987). A role for iron in oxidant-mediated ischemic injury to intestinal microvasculature.Am. J. Physiol.253(1 Pt 1), G49–G53.
Kloner, R.A., K. Przyklenk, and P. Whittaker (1989). Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.Circulation80(5), 1115–1127.
Beckman, J.S. and W.H. Koppenol (1996). Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly.Am. J. Physiol.271(5 Pt 1), C1424–C1437.
Wink, D.A., I. Hanbauer, M.C. Krishna, W. DeGraff, J. Gamson, and J.B. Mitchell (1993). Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species.Proc. Natl. Acad. Sci. USA90(21), 9813–9817.
Ma, X.L., P.S. Tsao, G.E. Viehman, and A.M. Lefer (1991). Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery.Circ. Res.69(1), 95–106.
Bolli, R. (1991). Oxygen-derived free radicals and myocardial reperfusion injury: An overview.Cardiovasc. Drugs Ther.5 (Supp12), 249–268.
Nossuli, T.O., R. Hayward, R. Scalia, and A.M. Lefer (1997). Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats.Circulation96(7), 2317–2324.
Lefer, D.J., R. Scalia, B. Campbell, T. Nossuli, R. Hayward, M. Salamonet al.(1997). Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats.J. Clin. Invest.99(4), 684–691.
Beckman, J.S., T.W. Beckman, J. Chen, P.A. Marshall, and B.A. Freeman (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.Proc. Natl. Acad. Sci. USA87(4), 1620–1624.
Ku, D.D. (1982). Coronary vascular reactivity after acute myocardial ischemia.Science218(4572), 576–578.
Pearson, P.J., P.J. Lin, and H.V. Schaff (1992). Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. A possible cUSAe of vasospasm after cardiopulmonary bypass.J. Thorac. Cardiovasc. Surg.103(6), 1147–1154.
Engelman, D.T., M. Watanabe, R.M. Engelman, J.A. Rousou, J.E. Flack III, D.W. Deatonet al.(1995). Constitutive nitric oxide release is impaired after ischemia and reperfusion.J. Thorac. Cardiovasc. Surg. 110(4 Pt 1), 1047–1053.
Giraldez, R.R., A. Panda, Y. Xia, S.P. Sanders, and J.L. Zweier (1997). Decreased nitric-oxide synthase activity cUSAes impaired endothelium-dependent relaxation in the postischemic heart.J. Biol. Chem.272(34), 21420–21426.
Gaballa, M.A. and S. Goldman (1999). Overexpression of endothelium nitric oxide synthase reverses the diminished vasorelaxation in the hindlimb vasculature in ischemic heart failure in vivo.J. Mol. Cell Cardiol.31(6), 1243–1252.
Wang, Q.D., E. Morcos, P. Wiklund, and J. Pemow (1997). L-arginine enhances functional recovery and Ca(2+)-dependent nitric oxide synthase activity after ischemia and reperfusion in the rat heart.J. Cardiovasc. Pharmacol.29(2), 291–296.
Wildhirt, S.M., R.R. Dudek, H. Suzuki, V. Pinto, K.S. Narayan, and R.J. Bing (1992). Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction.Cardiovasc. Res.29(4), 526–531.
Seccombe, J.F. and H.V. Schaff (1995). Coronary artery endothelial function after myocardial ischemia and reperfusion.Ann. Thorac. Surg.60(3), 778–788.
Ma, X.L., A.S. Weyrich, D.J. Lefer, and A.M. Lefer (1993). Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.Circ. Res.72(2), 403–412.
Bolli, R. (2001). Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: An overview of a decade of research.J. Mol. Cell Cardiol.33(11), 1897–1918.
Flogel, U., U.K. Decking, A. Godecke, and J. Schrader (1999). Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: A study in endothelial NO synthase knockout mice.J. Mol. Cell Cardiol.31(4), 827–836.
Kanno, S., P.C. Lee, Y. Zhang, C. Ho, B.P. Griffith, L.L. Shears IIet al.(2000). Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.Circulation101(23), 2742–2748.
Langrehr, J.M., R.A. Hoffman, T.R. Billiar, K.K. Lee, W.H. Schraut, and R.L. Simmons (1991). Nitric oxide synthesis in the in vivo allograft response: A possible regulatory mechanism.Surgery110(2), 335–342.
Cattell, V., J. Smith, A. Jansen, V. Riveros-Moreno, and S. Moncada (1994). Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat.Transplantation58(12), 1399–1402.
Langrehr, J.M., D.A. White, R.A. Hoffman, and R.L. Simmons (1993). Macrophages produce nitric oxide at allograft sites.Ann. Surg.218(2), 159–166.
Joies, J.A., I.H. Vos, H.J. Grone, and T.J. Rabelink (2002). Inducible nitric oxide synthase in renal transplantation.Kidney Int.61(3), 872–875.
Michel, T. and O. Feron (1997). Nitric oxide synthases: Which, where, how, and why?J. Clin. Invest.100(9), 2146–2152.
Kelly, R.A., J.L. Balligand, and T.W. Smith (1996). Nitric oxide and cardiac function.Circ. Res.79(3), 363–380.
Langrehr, J.M., N. Murase, P.M. Markus, X. Cai, P. Neuhaus, W. Schrautet al.(1992). Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat.J. Clin. Invest.90(2), 679–683.
Green, L.C., K. Ruiz de Luzuriaga, D.A. Wagner, W. Rand, N. Istfan, V.R. Younget al.(1981). Nitrate biosynthesis in man.Proc. Natl. Acad. Sci. USA78(12), 7764–7768.
Worrall, N.K., W.D. Lazenby, T.P. Misko, T.S. Lin, C.P. Rodi, P.T. Manninget al.(1995). Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase.J. Exp. Med.181(1), 63–70.
Tanaka, S., W. Kamiike, T. Ito, S. Nozaki, F. Uchikoshi, M. Miyataet al.(1995). Evaluation of nitric oxide during acute rejection after heart transplantation in rats.Transplant. Proc.27(1), 576–577.
Wildhirt, S.M., M. Weis, C. Schulze, N. Conrad, S. Pehlivanli, G. Riederet al.(2001). Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts.Circulation104(12 Suppl 1),1336–1343.
Mugge, A., S. Kurucay, R.H. Boger, S.M. Bode-Boger, H.J. Schafers, T. Wahlerset al.(1996). Urinary nitrate excretion is increased in cardiac transplanted patients with acute graft rejection.Clin. Transplant.10(3), 298–305.
Koglin, J., T. Glysing-Jensen, J.S. Mudgett, and M.E. Russell (1998). NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: Insights from NOS2-knockout mice. Am.J. Pathol.153(5), 1371–1376.
Yang, X., N. Chowdhury, B. Cai, J. Brett, C. Marboe, R.R. Sciaccaet al.(1994). Cannon, Induction of myocardial nitric oxide synthase by cardiac allograft rejection.J. Clin. Invest.94(2), 714–721.
Worall, N.K., T.P. Misko, P.M. Sullivan, J.J. Hui, and T.B. Ferguson Jr. (1996). Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection.Ann. Thorac. Surg.62(2), 378–385.
de Vera, M.E., R.A. Shapiro, A.K. Nussler, J.S. Mudgett, R.L. Simmons, S.M. Morris, Jr.et al.(1996). Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter.Proc. Natl. Acad. Sci. USA93(3), 1054–1059.
Chu, S.C., H.P. Wu, T.C. Banks, N.T. Eissa, and J. Moss (1995). Structural diversity in the 5’-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA.J. Biol. Chem.270(18), 10625–10630.
Eberhardt, W., C. Pluss, R. Hummel, and J. Pfeilschifter (1998). Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-lbeta and cAMP in rat mesangial cells.J. Immunol.160(10), 4961–4969.
Winlaw, D.S., C.G. Schyvens, G.A. Smythe, Z.Y. Du, S.P. Rainer, R.S. Lordet al.(1995). Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival.Transplantation60(1), 77–82.
Shiraishi, T., S.R. DeMeester, N.K. Worrall, J.H. Ritter, T.P. Misko, T.B. Ferguson, Jr.et al.(1995). Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection.J. Thorac. Cardiovasc. Surg.110(5), 1449–1459.
Szabolcs, M.J., J. Sun, N. Ma, A. Albala, R.R. Sciacca, G.B. Philipset al.(2002). Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection.Circulation106(18), 2392–2396.
Szabolcs, M.J., S. Ravalli, O. Minanov, R.R. Sciacca, R.E. Michler, and P.J. Cannonet al.(1998). Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection.Transplantation65(6) 804–812.
Szabolcs, M., R.E. Michler, X. Yang, W. Aji, D. Roy, E. Athanet al.(1996). Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase.Circulation94(7), 1665–1673.
Baldus, S., J.P. Eiserich, A. Mani, L. Castro, M. Figueroa, R. Chumleyet al.(2001). Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration.J. Clin. Invest.108(12), 1759–1770.
Suzuki, H., S.M. Wildhirt, R.R. Dudek, K.S. Narayan, A.H. Bailey, and R.J. Bing (1996). Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages.Tissue Cell.28(1), 89–97.
Haywood, G.A., P.S. Tsao, H.E. von der Leyen, M.J. Mann, P.J. Keeling, P.T. Trindade, Expression of inducible nitric oxide synthase in human heart failure.Circulation93(6), 1087–1094.
Lewis, N.P., P.S. Tsao, P.R. Rickenbacher, C. Xue, R.A. Johns, G.A. Haywoodet al.(1996). Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle.Circulation.93(4), 720–729.
Costanzo, M.R., D.C. Naftel, M.R. Pritzker, J.K. Heilman III, J.P. Boehmer, S.C. Brozenaet al.(1998). Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database.J. Heart Lung Transplant.17(8), 744–753.
Uretsky, B.F., S. Murali, P.S. Reddy, B. Rabin, A. Lee, B.P. Griffithet al.(1987). Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.Circulation76(4), 827–834.
Keogh, A.M., H.A. Valantine, S.A. Hunt, J.S. Schroeder, N. McIntosh, P.E. Oyeret al.(1992). Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation.J. Heart Lung Transplant.11(5), 892–901.
Salomon, R.N., C.C. Hughes, F.J. Schoen, D.D. Payne, J.S. Pober, and P. Libby (1991). Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.Am. J. Pathol.138(4), 791–798.
Rose, M.L. (1996). Role of antibody and indirect antigen presentation in transplant-associated coronary artery vasculopathy. J.Heart Lung Transplant.15(4), 342–349.
Johnson, M.R. (1992). Transplant coronary disease: Nonimmunologic risk factors.J. Heart Lung Transplant.11(3 Pt 2), S124–S132.
Park, J.W., M. Merz, P. Braun, and M. Vermeltfoort (1996). Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation.J. Heart Lung Transplant.15(6), 572–579.
Sasaguri, S., Y. Eishi, T. Tsukada, M. Sunamori, A. Suzuki, F. Numanoet al.(1990). Role of smooth-muscle cells and macrophages in cardiac allograft arteriosclerosis in rabbits.J. Heart Transplant.9(1), 18–24.
Billingham, M.E. (1987). Cardiac transplant atherosclerosis.Transplant. Proc.19(4 Suppl 5), 19–25.
Adams, D.H., M.E. Russell, W.W. Hancock, M.H. Sayegh, L.R. Wyner, and M.J. Karnovsky (1993). Chronic rejection in experimental cardiac transplantation: Studies in the Lewis-F344 model.Immunol. Rev. 1345–19.
Young-Ramsaran, J.O., R.H. Hruban, G.M. Hutchins, T.H. Phelps, W.A. Baumgartner, B.A. Reitzet al.(1993). Ultrastructural evidence of cell-mediated endothelial cell injury in cardiac transplant-related accelerated arteriosclerosis.Ultrastruct. Pathol.17(2), 125–136.
Libby, P. and H. Tanaka (1994). The pathogenesis of coronary arteriosclerosis (“chronic rejection”) in transplanted hearts.Clin. Transplant.8(3 Pt 2), 313–318.
Duquesnoy, R.J. and A.J. Demetris (1995). Immunopathology of cardiac transplant rejection.Curr. Opin. Cardiol.10(2), 193–206.
Russell, M.E., A.F. Wallace, L.R. Wyner, J.B. Newell, and M.J. Karnovsky (1995). Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis.Circulation.92(3), 457–464.
Rabinovitch, M., S. Molossi, and N. Clusaell (1995). Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: Efficacy of novel therapeutic approaches.J. Heart Lung Transplant.14(6 Pt 2), S116–5123.
Treasure, C.B., J.L. Klein, W.S. Weintraub, J.D. Talley, M.E. Stillabower, A.S. Kosinskiet al.(1995). Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.N. Engl. J. Med.332(8), 481–487.
Weis, M. and W. von Scheidt (1997). Cardiac allograft vasculopathy: A review.Circulation96(6), 2069–2077.
Ross, R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s.Nature362(6423), 801–809.
Davis, S.F., A.C. Yeung, I.T. Meredith, F. Charbonneau, P. Ganz, A.P. Selwynet al.(1996). Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant.Circulation.93(3), 457–462.
Marti, V., I. Romeo, R. Aymat, J. Garcia, P. Guiteras, M. Ballesteret al.(2001). Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation.J. Thorac. Cardiovasc. Surg.122(6), 1174–1180.
Sabate, M., A. Cequier, N. Manito, J. Mauri, J. Roca, J.A. Gomez-Hospitalet al.(2000). Predictive factors and long-term evolution of early endothelial dysfunction after cardiac transplantation.J. Heart Lung Transplant.19(5), 453–461.
Lee, P.C., Z.L. Wang, S. Qian, S.C. Watkins, A. Lizonova, I. Kovesdiet al.(2000). Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis.Transplantation69(6), 1186–1192.
Akyurek, L.M., B.C. Fellstrom, Z.Q. Yan, G.K. Hansson, K. Funa, and E. Larsson (1996). Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts. Am.J. Pathol.149(6), 1981–1990.
Ravalli, S., A. Albala, M. Ming, M. Szabolcs, A. Barbone, R.E. Michleret al.(1998). Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease.Circulation97(23), 2338–2345.
Lafond-Walker, A., C.L. Chen, S. Augustine, T.C. Wu, R.H. Hruban, and C.J. Lowenstein (1997). Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis. Am.J. Pathol.151(4), 919–925.
Baker, C.S., R.J. Hall, T.J. Evans, A. Pomerance, J. Maclouf, C. Creminonet al.(1999). Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages.Arterioscler. Thromb. Vasc. Biol. 19(3)646–655.
Kibbe, M., T. Billiar, and E. Tzeng (1999). Inducible nitric oxide synthase and vascular injury.Cardiovasc. Res.43(3), 650–657.
Yan, Z.Q., T. Yokota, W. Zhang, and G.K. Hansson (1996). Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery.Circ. Res. 79(1)38–44.
Mellion, B.T., L.J. Ignarro, C.B. Myers, E.H. Ohlstein, B.A. Ballot, A.L. Hymanet al.(1983). Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.Mol. Pharmacol.23(3), 653–664.
Radomski, M.W., R.M. Palmer, and S. Moncada (1987). Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.Lancet.2(8567), 1057–1058.
Hickey, M.J., K.A. Sharkey, E.G. Sihota, P.H. Reinhardt, J.D. Macmicking, C. Nathanet al.(1997). Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia.FASEB J.11(12), 955–964.
Guo, J.P., M.M. Panday, P.M. Consigny, and A.M. Lefer (1995). Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am.J. Physiol. 269(3 Pt 2), H1122–H1131.
Tzeng, E., Y.M. Kim, B.R. Pitt, A. Lizonova, I. Kovesdi, and T.R. Billiar (1997). Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis.Surgery122(2), 255–263.
Garg, U.C. and A. Hassid (1989). Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.J. Clin. Invest.83(5), 1774–1777.
McNamara, D.B., B. Bedi, H. Aurora, L. Tena, L.J. Ignarro, P.J. Kadowitzet al.(1993). L-arginine inhibits balloon catheter-induced intimai hyperplasia.Biochem. Biophys. Res. Commun. 193(1)291–296.
Marks, D.S., J.A. Vita, J.D. Folts, J.F. Keaney Jr, G.N. Welch, and J. Loscalzo (1995). Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide.J. Clin. Invest. 96(6)2630–2638.
Groves, P.H., A.P. Banning, W.J. Penny, A.C. Newby, H.A. Cheadle, and M.J. Lewis (1995). The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty.Cardiovasc Res. 30(1)87–96.
Lee, J.S., C. Adrie, H.J. Jacob, J.D. Roberts Jr, W.M. Zapol, and K.D. Bloch (1996). Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury.Circ. Res. 78(2)337–342.
Kibbe, M.R., J. Li, S. Nie, S.C. Watkins, A. Lizonova, I. Kovesdiet al.(2000). Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate.J. Vasc. Surg.31(6), 1214–1228.
Shears, L.L., N. Kawaharada, E. Tzeng, T.R. Billiar, S.C. Watkins, I. Kovesdiet al.(1997). Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.J. Clin. Invest. 100(8)2035–2042.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kanno, S., Shears, L.L., Billiar, T.R. (2004). Nitric Oxide, Oxygen Radicals. In: Wilkes, D.S., Burlingham, W.J. (eds) Immunobiology of Organ Transplantation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8999-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8999-4_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4754-5
Online ISBN: 978-1-4419-8999-4
eBook Packages: Springer Book Archive